These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32895389)

  • 1. Language disturbances in schizophrenia: the relation with antipsychotic medication.
    de Boer JN; Voppel AE; Brederoo SG; Wijnen FNK; Sommer IEC
    NPJ Schizophr; 2020 Sep; 6(1):24. PubMed ID: 32895389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data.
    Ozzoude M; Nakajima S; Plitman E; Chung JK; Kim J; Iwata Y; Caravaggio F; Takeuchi H; Uchida H; Graff-Guerrero A; Gerretsen P
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():207-213. PubMed ID: 30172739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis.
    Siafis S; Wu H; Wang D; Burschinski A; Nomura N; Takeuchi H; Schneider-Thoma J; Davis JM; Leucht S
    Mol Psychiatry; 2023 Aug; 28(8):3267-3277. PubMed ID: 37537284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.
    Muly EC; Votaw JR; Ritchie J; Howell LL
    J Pharmacol Exp Ther; 2012 Apr; 341(1):81-9. PubMed ID: 22214649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.
    de Bartolomeis A; Ciccarelli M; De Simone G; Mazza B; Barone A; Vellucci L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
    Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
    Neuropsychopharmacology; 2006 Sep; 31(9):1991-2001. PubMed ID: 16738543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking Screens of Noncovalent Interaction Motifs of the Human Subtype-D2 Receptor-75 Schizophrenia Antipsychotic Complexes with Physicochemical Appraisal of Antipsychotics.
    Amani P; Habibpour R; Karami L; Hofmann A
    ACS Chem Neurosci; 2021 Jun; 12(12):2218-2232. PubMed ID: 34061513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.
    Hopkins SC; Wilkinson S; Corriveau TJ; Nishikawa H; Nakamichi K; Loebel A; Koblan KS
    Clin Pharmacol Ther; 2021 Sep; 110(3):808-815. PubMed ID: 33961287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study.
    Fervaha G; Caravaggio F; Mamo DC; Mulsant BH; Pollock BG; Nakajima S; Gerretsen P; Rajji TK; Mar W; Iwata Y; Plitman E; Chung JK; Remington G; Graff-Guerrero A
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3803-3813. PubMed ID: 27557949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy.
    Oades RD; Rao ML; Bender S; Sartory G; Müller BW
    Behav Pharmacol; 2000 Jun; 11(3-4):317-30. PubMed ID: 11103886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data.
    Takeuchi H; Suzuki T; Bies RR; Remington G; Mamo DC; Pollock BG; Mimura M; Uchida H
    Schizophr Res; 2013 Nov; 150(2-3):373-9. PubMed ID: 24028745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dopamine D
    Egusquiza I; Munarriz-Cuezva E; Segarra R; González-Maeso J; Callado LF; Meana JJ; Diez-Alarcia R
    Pharmacol Rep; 2021 Aug; 73(4):1136-1146. PubMed ID: 34196951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What proportion of striatal D2 receptors are occupied by endogenous dopamine at baseline? A meta-analysis with implications for understanding antipsychotic occupancy.
    Caravaggio F; Iwata Y; Kim J; Shah P; Gerretsen P; Remington G; Graff-Guerrero A
    Neuropharmacology; 2020 Feb; 163():107591. PubMed ID: 30940535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG; Gil R; Hackett E; Mawlawi O; Zea-Ponce Y; Zhu Z; Kochan LD; Cangiano C; Slifstein M; Gorman JM; Laruelle M; Abi-Dargham A
    Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment.
    Weïwer M; Xu Q; Gale JP; Lewis M; Campbell AJ; Schroeder FA; Van de Bittner GC; Walk M; Amaya A; Su P; D Ordevic L; Sacher JR; Skepner A; Fei D; Dennehy K; Nguyen S; Faloon PW; Perez J; Cottrell JR; Liu F; Palmer M; Pan JQ; Hooker JM; Zhang YL; Scolnick E; Wagner FF; Holson EB
    ACS Chem Biol; 2018 Apr; 13(4):1038-1047. PubMed ID: 29485852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique effect of clozapine on adenosine A
    Valle-León M; Casajuana-Martin N; Del Torrent CL; Argerich J; Gómez-Acero L; Sahlholm K; Ferré S; Pardo L; Ciruela F
    Biomed Pharmacother; 2023 Apr; 160():114327. PubMed ID: 36736280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation in Pharmacokinetic Attenuation Between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic Review.
    Kurose S; Mimura Y; Uchida H; Takahata K; Kim E; Suzuki T; Mimura M; Takeuchi H
    J Clin Psychiatry; 2020 Jul; 81(5):. PubMed ID: 32726002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications.
    de Haan L; Lavalaye J; van Bruggen M; van Nimwegen L; Booij J; van Amelsvoort T; Linszen D
    Can J Psychiatry; 2004 May; 49(5):290-6. PubMed ID: 15198464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.